Genoox Raises $8M in Funding

Amir Trabelsi, CEO of Genoox
Amir Trabelsi, CEO of Genoox

Genoox, a Palo Alto in CA-based driven genomic data platform provider, raised $8M in funding.

The round was led by IN Venture, a Sumitomo Corporation backed venture fund, with participation from Infinity Medical and existing investors Inimiti, Glilot Capital and Triventures.

The company intends to use the funds to expand its community of genetic professional users and enhance the network effect created by sharing genetic insights on its platform.

Genoox provides a community-driven genomic data platform connecting clinicians, genetic counsellors, and healthcare organizations. The platform is used by over 1500 genetic labs and health systems across the globe, from the U.S. to Europe, Australia to Asia and the Latin America region.

Additionally, the company announced that Ohad Arazi has been appointed as Chairman of the Board. Arazi has been a technology executive and digital health innovator for 20 years, spanning Israel and North America. He began his career as an entrepreneur and later served as SVP and GM with McKesson and Change Healthcare’s medical imaging group. He then went on to become Chief Strategy Officer for TELUS Health and most recently served as Chief Executive Officer of imaging AI company, Zebra Medical Vision. Arazi is currently the Entrepreneur-In-Residence for Telus Ventures.